Literature DB >> 31469909

Factors associated with acute exacerbations of myasthenia gravis.

Rohit Reddy Gummi1, Natalie Anna Kukulka1, Chelsea B Deroche2, Raghav Govindarajan3.   

Abstract

INTRODUCTION: The etiology of acute exacerbations of myasthenia gravis (MG) is not well understood and further characterization can lead to improved preventative measures. This study aims to characterize factors contributing to MG exacerbations.
METHODS: A total of 127 MG patient charts were reviewed retrospectively (2011-2016) to obtain demographics, immunizations, pharmaceutical records, contributing factors of each MG exacerbation, emergency department (ED) visits, hospitalizations, and duration.
RESULTS: There were 212 exacerbations requiring 106 ED visits and 141 hospitalizations (average admission 6.5 days). Highest contributors were infections (30%) and medications that may worsen MG (19%), with 24% unattributed. Infection related exacerbations were associated with 44.3% of ED visits and 39.7% of hospitalizations. Patients prescribed beta-blockers were associated with more exacerbations (P < .01). Patients prescribed medications that may worsen MG had a higher exacerbation frequency shortly after administration. DISCUSSION: Infections and cautioned medications are frequently factors in acute MG exacerbations needing urgent medical attention and warrant caution.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  exacerbation; infection; medication; myasthenia gravis; vaccine

Mesh:

Substances:

Year:  2019        PMID: 31469909     DOI: 10.1002/mus.26689

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  30 in total

1.  Cardiac disorders worsen the final outcome in myasthenic crisis undergoing non-invasive mechanical ventilation: a retrospective 20-year study from a single center.

Authors:  Erika Iori; Alessandra Ariatti; Marco Mazzoli; Elisabetta Bastia; Manuela Gozzi; Virginia Agnoletto; Alessandro Marchioni; Giuliana Galassi
Journal:  Acta Myol       Date:  2022-03-31

2.  Bilateral Vocal Cord Palsy as the Only Symptom of Thymoma Associated-Myasthenia Gravis.

Authors:  Despoina Beka; Chrysoula Marogianni; Styliani Ralli; Ourania Karyda; Jiannis Hatziioannou; Georgios M Hadjiigeorgiou; Efthimios Dardiotis; Ioannis Bizakis; Charalampos E Skoulakis; Vasileios A Lachanas
Journal:  Maedica (Bucur)       Date:  2022-03

3.  COVID-19 and Sepsis in an Atypical Case of Mixed Connective Tissue Disorder Presenting With a Myasthenic Crisis.

Authors:  Lav Kumar Shah; Biswas Pant; Nashruva Mony; Sumitanand Mishra; Januka Gaire; Sandesh Sharma
Journal:  Cureus       Date:  2022-09-12

4.  Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience.

Authors:  Mirjana Zdraljevic; Stojan Peric; Marta Jeremic; Dragana Lavrnic; Ivana Basta; Ljiljana Hajdukovic; Dejana R Jovanovic; Ivana Berisavac
Journal:  Neurol Sci       Date:  2022-09-09       Impact factor: 3.830

Review 5.  Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians.

Authors:  Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid
Journal:  Open Forum Infect Dis       Date:  2022-06-15       Impact factor: 4.423

Review 6.  Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management.

Authors:  Fiammetta Vanoli; Renato Mantegazza
Journal:  Neurotherapeutics       Date:  2022-02-14       Impact factor: 6.088

Review 7.  Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era.

Authors:  Yung-Hao Tseng; Tai-Heng Chen
Journal:  Front Neurol       Date:  2021-03-24       Impact factor: 4.003

8.  COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.

Authors:  Swathi Beladakere Ramaswamy; Raghav Govindarajan
Journal:  J Neuromuscul Dis       Date:  2020

Review 9.  Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic.

Authors:  Gianluca Costamagna; Elena Abati; Nereo Bresolin; Giacomo Pietro Comi; Stefania Corti
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849

10.  COVID-19 in patients with myasthenia gravis.

Authors:  Pria Anand; Michaël C C Slama; Michelle Kaku; Charlene Ong; Anna M Cervantes-Arslanian; Lan Zhou; William S David; Amanda C Guidon
Journal:  Muscle Nerve       Date:  2020-05-22       Impact factor: 3.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.